Actively Recruiting
Evaluation of Gut-Related Well-Being and Mood Effects of a Daily Nutritional Food Ingredient From the Co-Fermentation of Fungal Mycelium (Pleurotus Pulmonarius) and Microalgae (Chlorella Vulgaris)
Led by Koralo GmbH · Updated on 2026-02-12
80
Participants Needed
1
Research Sites
17 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to evaluate the gut-related well-being and mood effects of a food ingredient obtained from the co-fermentation of oyster mushroom mycelium (Pleurotus pulmonarius), microalgae (Chlorella vulgaris), and bamboo fibre in healthy adults (aged 18+) experiencing minor gastrointestinal discomfort during an intervention period of 30 days. The participants will be allocated into two unbalanced groups to determine relationships between the measurable outcomes and the dose levels at three different time points: start of the study (baseline), 15 days (middle), and 30 days (end-point), during which participants will be asked to complete GSRS and POMS-2-SF questionnaire
CONDITIONS
Official Title
Evaluation of Gut-Related Well-Being and Mood Effects of a Daily Nutritional Food Ingredient From the Co-Fermentation of Fungal Mycelium (Pleurotus Pulmonarius) and Microalgae (Chlorella Vulgaris)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older
- Generally healthy individuals
- Experience minor, non-clinical gastrointestinal discomfort at least twice per week for 63 months
- Willing to consume the study product once daily for 30 days
- Able to dissolve and consume the powdered product in a beverage
- Able to read, understand, and complete electronic questionnaires in English
- Access to a smartphone or computer for study participation
- Provide electronic informed consent
You will not qualify if you...
- Diagnosed gastrointestinal disease (e.g., IBS, IBD, GERD requiring medication)
- Use of medications affecting gastrointestinal function or mood within the past 30 days
- Initiation of new gut-, immune-, or mood-related supplements within 15 days prior to study start
- Known allergy or sensitivity to study product components
- Pregnancy or breastfeeding
- Major chronic medical condition that could interfere with study participation or data interpretation
- Participation in another interventional clinical study within the past 30 days
- Inability or unwillingness to comply with study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Alethios, Inc.
San Francisco, California, United States, 94109
Actively Recruiting
Research Team
G
Guido Albanese, PhD
CONTACT
Z
Zoe Benham, B.S.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here